NBP
Novabridge Biosciences
$1.78
+$0.01 (+0.56%)Jul 27, 2026
Key metrics
The numbers that frame NBP today
- Market cap
- $205.48M
- P/E (TTM)
- -4.4
- EV / FCF
- 0.1
- ROIC
- -73.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.46
- 52wk High
- $6.79
Growth
Revenue and earnings trend for NBP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NBP
Is Novabridge Biosciences a good buy?
No. Novabridge Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of NBP?
Novabridge Biosciences's market capitalization is $205.48M.
What is the P/E ratio for NBP stock?
Novabridge Biosciences's current P/E ratio is -4.4.
What is the 52-week high for NBP stock?
The 52-week high for Novabridge Biosciences is $6.79. The current close of $1.78 is 73.8% below that high.
What is the 52-week low for NBP stock?
The 52-week low for Novabridge Biosciences is $1.46. The current close of $1.78 is 21.9% above that low.
Does NBP stock pay dividends?
Novabridge Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NBP?
Novabridge Biosciences's Debt / Equity ratio is 0.01.